ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,923Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 1290

$489K Total Retail Price of All Prescriptions

Rank: 206 out of 1290

520 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 520 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,606 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 747 664 1 1
LISINOPRIL 653 563 2 5
OMEPRAZOLE 653 589 2 2
METFORMIN HCL 397 339 4 10
HYDROCHLOROTHIAZIDE 362 332 5 20
AMLODIPINE BESYLATE 350 333 6 3
METOPROLOL TARTRATE 342 299 7 7
ATENOLOL 310 275 8 18
FUROSEMIDE 260 223 9 9
LEVOTHYROXINE SODIUM 258 233 10 4
GLIPIZIDE 218 199 11 81
LOSARTAN POTASSIUM 212 205 12 19
IBUPROFEN 199 173 13 74
CRESTOR 163 133 14 17
CARVEDILOL 152 128 15 12
ENALAPRIL MALEATE 132 130 16 62
POTASSIUM CHLORIDE 132 130 16 35
TAMSULOSIN HCL 124 120 18 11
PLAVIX 121 108 19 32
LANTUS 120 93 20 67
ALENDRONATE SODIUM 112 104 21 39
GABAPENTIN 104 82 22 8
DONEPEZIL HCL 99 92 23 13
METOPROLOL SUCCINATE 99 99 23 14
MECLIZINE HCL 98 97 25 159
CLOPIDOGREL 95 85 26 24
TEMAZEPAM 90 88 27 71
DIOVAN 89 66 28 53
NIFEDIPINE ER 85 79 29 110
SINGULAIR 84 75 30 85
LANSOPRAZOLE 83 76 31 181
TRAMADOL HCL 79 74 32 25
CLONIDINE HCL 78 77 33 66
DIGOXIN 77 64 34 51
SURE COMFORT 75 66 35 214
INSULIN SYRINGE 74 50 36 76
RANITIDINE HCL 72 59 37 49
VIAGRA 72 65 37 124
ZOLPIDEM TARTRATE 71 56 39 15
VOLTAREN 70 62 40 107
FAMOTIDINE 68 63 41 128
NAMENDA 68 60 41 27
LOSARTAN-HYDROCHLOROTHIAZIDE 67 61 43 106
GLYBURIDE-METFORMIN HCL 66 59 R 44 147
NEXIUM 66 62 44 34
CLOTRIMAZOLE-BETAMETHASONE 59 58 46 153
CELEBREX 55 49 47 111
ALPRAZOLAM 53 47 48 47
QUETIAPINE FUMARATE 52 47 49 80
DIOVAN HCT 52 50 49 112
ADVAIR DISKUS 51 44 51 37
VENTOLIN HFA 50 50 52 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.